Arcus Biosciences Inc (RCUS)
Current ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 1,016,000 | 1,127,000 | 1,022,000 | 1,064,000 | 831,000 | 882,000 | 986,000 | 1,015,000 | 1,067,000 | 1,101,120 | 1,227,480 | 1,264,230 | 1,262,000 | 545,288 | 745,954 | 841,870 | 735,815 | 797,199 | 471,599 | 166,217 |
| Total current liabilities | US$ in thousands | 226,000 | 215,000 | 199,000 | 204,000 | 184,000 | 200,000 | 180,000 | 179,000 | 193,000 | 177,176 | 164,024 | 161,254 | 166,000 | 142,866 | 130,370 | 132,055 | 121,669 | 162,871 | 40,025 | 21,004 |
| Current ratio | 4.50 | 5.24 | 5.14 | 5.22 | 4.52 | 4.41 | 5.48 | 5.67 | 5.53 | 6.21 | 7.48 | 7.84 | 7.60 | 3.82 | 5.72 | 6.38 | 6.05 | 4.89 | 11.78 | 7.91 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,016,000K ÷ $226,000K
= 4.50
The current ratio of Arcus Biosciences Inc has shown fluctuation over the past few years, ranging from a high of 11.78 in June 2020 to a low of 3.82 in September 2021 before stabilizing within the range of 4.41 to 7.84 from March 2022 to June 2024. This ratio indicates the company's ability to cover its short-term liabilities with its current assets. Higher current ratios suggest better liquidity and financial stability, while lower ratios may raise concerns about the company's ability to meet its short-term obligations. Overall, Arcus Biosciences Inc has maintained current ratios above 4 in recent periods, indicating a reasonable ability to meet its short-term financial obligations.
Peer comparison
Dec 31, 2024